Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, March 11, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Roanna Ruiz Maintained (ALGS) at Buy with Increased Target to $275 on, Mar 11th, 2022
Roanna Ruiz of SVB Leerink, Maintained "Aligos Therapeutics, Inc." (ALGS) at Buy with Increased Target from $250 to $275 on, Mar 11th, 2022.
Roanna has made no other calls on ALGS in the last 4 months.
There is 1 other peer that has a rating on ALGS. Out of the 1 peers that are also analyzing ALGS, all agrees with Roanna's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Eric Joseph of "JP Morgan" Downgraded from Buy to Hold and Decreased Target to $300 on, Friday, January 7th, 2022
